Phase I trial of a treatment of nivolumab combined with stereotactic body radiotherapy for patients with multiple metastatic non-small cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms NIVOSTLUC-1
- 15 Sep 2016 Status changed from not yet recruiting to recruiting.
- 19 Aug 2016 New trial record